The Case for Mesocaval Shunts in the Treatment of Portal Hypertension

  • Marvin L. Gliedman
  • Ronald N. Kaleya
Conference paper


Reflecting on the use of portosystemic shunts in the treatment of variceal bleeding associated with portal hypertension, it has become obvious that reduction of portal venous pressure addresses only one facet of the overall problem in patients with severely diseased livers. With limited hepatic reserve, selection of a particular portal decompression procedure for an individual patient may have a significant effect on that patient’s survival freedom from variceal hemorrhage, quality of life as determined by the absence of hepatic encephalopathy, and candidacy for subsequent liver transplantation.


Portal Hypertension Hepatic Encephalopathy Esophageal Varix Variceal Bleeding Splenic Vein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Eck NV. On the question of ligature of the portal vein. Surg Gynecol Obstet 1953;96:375.Google Scholar
  2. 2.
    Marion P. Les obstructiones portales. Semin Hop Paris 1953;29:2781.Google Scholar
  3. 3.
    Clatworthy WH, Wall T, Watman R. A new type of portal to systemic venous shunt for portal decompression. Arch Surg 1955;71:588.Google Scholar
  4. 4.
    Gliedman ML. The mesocaval shunt for portal hypertension. Am J Gstroenterol 1971;56:323.Google Scholar
  5. 5.
    Drapanas T. Interposition mesocaval shunt for the treatment of portal hypertension. Ann Surg 1972;176:435.PubMedGoogle Scholar
  6. 6.
    Mitchell RL, Ignatius JA. Distal splenorenal shunt: Standard procedure for elective and emergency treatment of bleeding esophageal varices. Am J Surg 1988;156:169.PubMedCrossRefGoogle Scholar
  7. 7.
    Mehigan DG, Zuiderma GD, Cameron JL. The incidence of shunt occlusion following portasystemic decompression. Surg Gynecol Obstet 1980;150:661.PubMedGoogle Scholar
  8. 8.
    Henderson JM. Variceal bleeding, Which shunt? Gastroenterology 1986; 91:1021.PubMedGoogle Scholar
  9. 9.
    McInnes IE, Gibson PR, Rosengarten DS, et al. Long term followup of patients following selective and nonselective portosystemic shunts. Aust NZ J Surg 1985;55:355.Google Scholar
  10. 10.
    Ruff RJ, Chuang VP, Alspaugh JP, et al. Percutaneous vascular intervention after surgical shunting for portal hypertension. Radiology 1987;164:469.PubMedGoogle Scholar
  11. 11.
    Rocko JM, Howard MM, Swan KG. Surgical management of bleeding esophageal varices. Am Surg 1986;52:81.PubMedGoogle Scholar
  12. 12.
    Mulcare RJ, Halleran D, Gardine R. Experience with 49 consecutive Dacron interposition mesocaval shunts. Am J Surg 1984;147:393.PubMedCrossRefGoogle Scholar
  13. 13.
    Langer B, Taylor BR, Mackenzie DR, et al. Further report of a prospective randomized trial comparing the DSRS with end to side portacaval shunt. Gastroenterology 1985;88:424.PubMedGoogle Scholar
  14. 14.
    Rigau J, Teres J, Visa J, et al. Long term followup of 100 patients treated by a modified splenorenal shunt. Br J Surg 1986;73:708.PubMedCrossRefGoogle Scholar
  15. 15.
    Brems JJ, Hiatt JR, Klein AS, et al. Effect of a prior portasystemic shunt on subsequent liver transplantation. Ann Surg 1989;209:51.PubMedCrossRefGoogle Scholar
  16. 16.
    Paquet KJ, Kalk JF, Koussouns P. Prospective evaluation and long term results of mesocaval interposition shunts. Acta Chir Scand 1987;153:423.PubMedGoogle Scholar
  17. 17.
    Terpstra OT, Ausema B, Bruining HA, et al. Late results of mesocaval interposition shunting for bleeding esophageal varices. Br J Surg 1987;74:787.PubMedCrossRefGoogle Scholar
  18. 18.
    Sarr MG, Herlong HF, Cameron JL. Long term patency of mesocaval C-shunts. Am J Surg 1986;151:98.PubMedCrossRefGoogle Scholar
  19. 19.
    Vogt DP, Santoscoy T, Cooperman AM, et al. Surgical management of portal hypertension and esophageal varices. Am J Surg 1983;146:274.PubMedCrossRefGoogle Scholar
  20. 20.
    Jarvinen H, Kallio H, Lempinen M. Interposition mesocaval shunts for bleeding esophageal varices in moderate and poor risk cirrhotics. Ann Chir Gynaecol 1981;70:45.PubMedGoogle Scholar
  21. 21.
    Fletcher M, Dawson J, Williams R. Long term followup of mesocaval shunting in portal hyptertension. Br J Surg 1981;68:485.PubMedCrossRefGoogle Scholar
  22. 22.
    Smith RB, Warren WD, Salam AA, et al. Dacron interposition shunts for portal hypertension. Ann Surg 1980;192:9.PubMedCrossRefGoogle Scholar
  23. 23.
    Reichle F, Fahmy W, Golsorkhi M. Prospective comparative clinical trial with distal splenorenal and mesocaval shunts. Am J Surg 1979;137:13.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1992

Authors and Affiliations

  • Marvin L. Gliedman
  • Ronald N. Kaleya

There are no affiliations available

Personalised recommendations